Call 14 of the Innovative Medicines Initiative. 

The Innovative Medicines Initiative (IMI) is a partnership between the European Union and the European pharmaceutical industry. IMI facilitates open collaboration in research to advance the development of, and accelerate patient access to, personalised medicines for the health and wellbeing of all, especially in areas of unmet medical need.

Topics

• Topic 1: Targeted immune intervention for the management of non-response and relapse
• Topic 2: Non-invasive clinical molecular imaging of immune c